890,000 Hypertension Patients in Their 20s and 30s
Macular Degeneration and Glaucoma Cases Up 30%
Raising Awareness of Health Management Among Young People
Daewoong Pharmaceutical announced on the 29th that it participated in the 'Jeonju Ultimate Music Festival (JUMF 2025)', held from August 15 to 17 at the main stadium of Jeonbuk National University. The company conducted the '2030 Early Detection in Daily Life' campaign with citizens, focusing on blood pressure, arrhythmia, and eye health, and supported fatigue management by providing hands-on experiences with Urushot and Impactamune.
A participant at the Jeonju Music Festival is taking part in an experience event where fatigue is relieved using a gaming hammer. Daewoong Pharmaceutical
Celebrating its 10th anniversary this year, JUMF is a leading summer music festival featuring top artists from Korea and abroad. The festival offers more than 11 hours of live performances and various experience booths in the heart of the city. Leveraging the festival's appeal to a young audience, Daewoong Pharmaceutical carried out activities to spread the message of early screening among people in their 20s and 30s.
This campaign emphasized that the younger generation is not in a safety zone. According to the Korean Society of Hypertension, there are about 890,000 hypertension patients in their 20s and 30s, but only 130,000 are consistently receiving treatment, highlighting a significant gap in management among young people. Additionally, statistics from the Korean Heart Rhythm Society show that the prevalence of atrial fibrillation in Korea has nearly doubled over the past 10 years. According to the Health Insurance Review and Assessment Service, vision-related diseases such as macular degeneration and glaucoma have also increased by about 30% among people in their 20s and 30s over the past five years, indicating a clear upward trend in these conditions among the younger generation.
The on-site booth was designed as an interactive experience to encourage healthy behavior changes. Participants could check their own risk signals through a blood pressure management quiz and an eye health sticker quiz, and learn preventive measures that can be practiced in daily life. In addition, elements such as game-based experiences, a photo booth, and tattoo sticker giveaways were incorporated to enhance the accessibility of the campaign's message.
Daewoong Pharmaceutical introduced CART BP, a home-use ring-type blood pressure monitor scheduled for release at the end of this year, emphasizing the importance of 'continuous blood pressure management in daily life.' Since hypertension and arrhythmia in young people are often asymptomatic and are frequently detected late, the company stressed the importance of using wearable devices to monitor changes regularly and visiting medical institutions for accurate diagnosis when necessary. The company also suggested that attendees in their 20s and 30s consider 'blood pressure management gifts for parents' as a way to take care of family health.
At the 2025 Jeonju Music Festival (JUMF), attendees experienced Daewoong Pharmaceutical's 'Urushot' and 'Impactamune' firsthand. Daewoong Pharmaceutical
CART BP is a ring-type continuous blood pressure monitor developed to address the drawbacks of conventional cuff-type ambulatory blood pressure monitors (ABPM), such as sleep disturbances and behavioral restrictions. By simply wearing CART BP on a finger, its artificial intelligence (AI) system automatically analyzes the user's blood pressure patterns. Notably, it enables 24-hour continuous blood pressure measurement and monitoring, making it possible to adjust medication dosages based on time-specific blood pressure data and to effectively track changes in blood pressure related to lifestyle factors such as sleep, exercise, alcohol consumption, and antihypertensive medication use.
Given that long hours of viewing and outdoor activities at the festival can easily lead to accumulated fatigue, Daewoong Pharmaceutical provided trial products of Urushot and Impactamune on-site, along with tips for consumption to help with fatigue recovery and condition management. Attendees could directly try and experience the products on the spot, making it easy to understand their functions and key benefits.
Impactamune contains active vitamin B1 (benfotiamine), which offers up to 9.3 times higher bioavailability than the inactive form for rapid absorption. It also combines seven types of vitamin B, as well as vitamins D and E, and zinc, delivering 10 essential nutrients in a single tablet for convenient fatigue recovery. Urushot is a product approved by the Ministry of Food and Drug Safety for 'physical fatigue improvement,' featuring a unique formulation of 30ml of UDCA per day, supplemented with vitamins B1, B2, E, and zinc. Both products are manufactured under Daewoong Pharmaceutical's strict quality control system, meeting GMP (Good Manufacturing Practice) standards.
The company also announced the upcoming launch in September of a collaborative product with the global esports team T1. An 'Insaengnecut Photo Booth' was operated, allowing attendees to take photos as if with T1 players, including world-renowned pro-gamer Faker Lee Sanghyeok. These certified photos spread on social media, naturally increasing online attention.
Cho Byungha, Head of Digital Healthcare at Daewoong Pharmaceutical, stated, "Our goal in participating was to raise health awareness at lifestyle touchpoints like music festivals, promote the habit of early detection through easy-to-use digital health devices, and enable attendees to directly experience fatigue recovery and vitality with convenient products." He added, "We will continue to contribute to the prevention and management of chronic diseases among the younger generation-the future leaders-through participatory ESG health campaigns tailored to regional and generational characteristics."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
